Ever-increasing demand from our customers for novel products and highly technical solutions has led us to add to our accomplished team, and we are confident that Scott will be a great asset to our customers on many levels.
Warrington, PA (PRWEB) May 20, 2014
Polysciences, Inc., an award-winning company specializing in the development and manufacture of high purity chemicals and reagents for laboratory research, histology, healthcare diagnostics and biomedical applications, has named Scott Knorr as Director of Lab Products Bulk & Synthesis. In this newly created position, Knorr will be responsible for executing market development, sales and new business plans for the company’s Lab Products division.
Knorr will join Dr. Joel Coret, Polysciences' CTO, and his team in the on-going development of novel monomers, polymers, and fine chemicals used in diverse biomedical applications, such as ophthalmic lenses and drug delivery devices, as well as specialty industrial applications. Knorr brings a wealth of knowledge and over 20 years of experience in the chemical industry, focused on commercializing innovative, high-value, custom components for medical, pharmaceutical and specialty industrial applications.
Commenting on his appointment Knorr stated, “Polysciences offers a unique combination of material expertise, manufacturing capabilities and custom development to assist customers in bringing new products to market. I’m excited to join the team and look forward to contributing to the organization’s ongoing successes.”
Prior to joining Polysciences, Knorr held key positions with Adhesives Research, Inc. (Glen Rock, PA), overseeing the company’s global business activities as a component supplier to the medical device, diagnostic and wound care industries. Knorr received his Bachelor of Science degree in Chemical Engineering from The Pennsylvania State University (State College, PA) and Masters of Business Administration from the University of Maryland - Robert H. Smith School of Business (College Park, MD).
“Scott Knorr's appointment signifies our on-going commitment to customers to expand our product offerings for medical device and drug delivery applications,” said Michael Ott, President and CEO. “Ever-increasing demand from our customers for novel products and highly technical solutions has led us to add to our accomplished team, and we are confident that Scott will be a great asset to our customers on many levels.”
About Polysciences, Inc.:
Polysciences, Inc. was founded in 1961 and specializes in the development and manufacture of high purity chemicals and reagents for laboratory research, histology, healthcare diagnostics and medical devices. Materials developed for the biomedical and pharmaceutical industries have helped bring about countless innovations in healthcare as well as in high performance adhesives and personal care products. More information about Polysciences, Inc. can be found at http://www.polysciences.com.